SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-504202"
 

Search: onr:"swepub:oai:DiVA.org:uu-504202" > Comparative Analysi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Argirion, Ilona (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Pfeiffer, Ruth M. (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Proietti, Carla (author)
James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Cairns, Qld, Australia.
show more...
Coghill, Anna E. (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.;H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Div Populat Sci, Tampa, FL USA.
Yu, Kelly J. (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Middeldorp, Jaap M. (author)
Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.
Sarathkumara, Yomani D. (author)
James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Cairns, Qld, Australia.
Hsu, Wan-Lun (author)
Fu Jen Catholic Univ, Coll Med, Master Program Big Data Biomed, New Taipei, Taiwan.;Fu Jen Catholic Univ, Coll Med, Data Sci Ctr, New Taipei, Taiwan.
Chien, Yin-Chu (author)
Acad Sinica, Genom Res Ctr, Taipei, Taiwan.;Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.
Lou, Pei-Jen (author)
Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan.
Wang, Cheng-Ping (author)
Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan.
Rothman, Nathaniel (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Lan, Qing (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Chen, Chien-Jen (author)
Acad Sinica, Genom Res Ctr, Taipei, Taiwan.;Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
Mbulaiteye, Sam M. (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Jarrett, Ruth F. (author)
Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
Glimelius, Ingrid, 1975- (author)
Karolinska Institutet,Uppsala universitet,Institutionen för immunologi, genetik och patologi
Smedby, Karin E. (author)
Karolinska Institutet
Hjalgrim, Henrik (author)
Statens Serum Inst, Copenhagen, Denmark.;Rigshosp, Dept Haematol, Copenhagen, Denmark.
Hildesheim, Allan (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
Doolan, Denise L. (author)
James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Cairns, Qld, Australia.
Liu, Zhiwei (author)
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
show less...
NCI, Div Canc Epidemiol & Genet, Rockville, MD USA James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Cairns, Qld, Australia. (creator_code:org_t)
American Association For Cancer Research (AACR), 2023
2023
English.
In: Cancer Epidemiology, Biomarkers and Prevention. - : American Association For Cancer Research (AACR). - 1055-9965 .- 1538-7755. ; 32:5, s. 687-696
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Epstein-Barr virus (EBV) is linked to multiple cancers, including classical Hodgkin lymphoma (cHL), endemic Burkitt lymphoma (eBL), nasopharyngeal carcinoma (NPC), and extranodal natural killer/T-cell lymphoma (NKTCL).Methods: Anti-EBV IgG and IgA antibody responses target-ing 202 sequences from 86 EBV proteins were measured using the same EBV whole proteome array across four case-control studies investigating EBV-positive cHL, eBL, NPC, and NKTCL (407 cases/620 controls). We grouped EBV-targeted antibodies into pathways by immunoglobulin type (IgA and IgG) and life-cycle stage (latent, immediate early lytic, early lytic, late lytic, and glycoprotein) and evaluated their associ-ation with each cancer type. In an additional analysis, we focused on the subset of 46 individual antibodies repre-senting the top candidates for each cancer and compared their associations across the four cancer types using multivariable linear regression models.Results: IgA antibody responses targeting all EBV life-cycle stages were associated with NPC but limited to anti-early lytic stage for cHL. NPC and eBL were associated with IgG antibodies across the viral life cycle; cHL with antibodies in the early lytic, late lytic and glyco-protein stages; and NKTCL with antibodies in the latent, immediate early lytic and early lytic phases. EBNA3A, BBLF1, BDLF4, and BLRF2 IgG antibodies were associated with all cancer types.Conclusions: Our observed similarities and differences across four EBV-associated cancers may inform EBV-related oncogenesis.Impact: Understanding the comparative humoral immune response across EBV-related cancers may aid in identifying shared etiologic roles of EBV proteins and inform unique pathogenic processes for each cancer.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view